TCM firms find gold in overseas markets

Companies ride the crest of success as govt reiterates support

Traditional Chinese medicine makers are expanding their presence in the global markets in a big way, as the government reiterated its support to further strengthen the sector.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, the largest patent drugmaker in China, is setting up a 200 million yuan ($30.87 million) fund to expand its overseas TCM presence in the next five years, according to company officials.